Abstract: An example method of the present disclosure comprises imbibing a Cannabaceae seed in a hydration solution, excising a subset of embryonic tissue from the imbibed Cannabaceae seed to extract a Cannabaceae meristematic region or embryonic axis (EA), and exposing the Cannabaceae meristematic region or EA to a heterologous nucleotide sequence to transform Cannabaceae cells of the Cannabaceae meristematic region or EA.

Abstract: Embodiments of the present disclosure are directed to a method for producing a grafted plant for delivery of genome editing reagents. The method may include grading cultured rootstock tissue to obtain at least one rootstock expressing an expression construct and having a stem with a graft-compatible diameter and genotype, and making a cut through the at least one rootstock stem and placing a stabilization device adjacent to the cut on the rootstock stem. The method may further include generating a grafted plant by inserting at least one cut scion stem into the stabilization device, wherein the at least one cut scion stem substantially aligns with vascular tissue within the cut rootstock stem, and screening new growth from the grafted plant for gene edits resulting from genomic editing by the expression construct.

Abstract: The present disclosure provides fatty acid desaturase 2 (FAD2) genes and plants and/or plant cells bearing one or more mutations in two or more FAD2 genes; as well as methods of making and using such plants. In some embodiments, plants producing seed oil with high oleic acid content are provided.

Abstract: Provided are mutated acetohydroxyacid synthase (AHAS) nucleic acids and the proteins encoded by the mutated nucleic acids. Also provided are canola plants, cells, and seeds comprising the mutated genes.

Abstract: The present invention relates to the production of a non-transgenic plant resistant or tolerant to a herbicide of the phosphonomethylglycine family, e.g., glyphosate. The present invention also relates to the use of a recombinagenic oligonucleobase to make a desired mutation in the chromosomal or episomal sequences of a plant in the gene encoding for 5-enol pyruvylshikimate-3-phosphate synthase (EPSPS). The mutated protein, which substantially maintains the catalytic activity of the wild-type protein, allows for increased resistance or tolerance of the plant to a herbicide of the phosphonomethylglycine family, and allows for the substantially normal growth or development of the plant, its organs, tissues or cells as compared to the wild-type plant irrespective of the presence or absence of the herbicide. Additionally the present invention relates to mutant E. coli cells that contain mutated EPSPS genes.

Abstract: Mixed duplex oligonucleotides (MDON) are used to effect site-specific genetic alterations in a target DNA sequence of a plant. The MDON are introduced by electroporation into microspores. Thereafter, plants having a desired genetic alteration are produced by germinating the microspores.